MedTrace Logo

L-arginine Effects on Chronic Hypertension in Pregnancy

NCT00974714 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-01-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of oral L-arginine administration on pregnant women at second trimester of gestation with chronic hypertension, respect with placebo.

Conditions

  • Hypertension in Pregnancy

Interventions

DRUG

L-arginine

Oral L-arginine 2 g twice a day for 14 weeks

OTHER

placebo

oral placebo 2 g twice a day for 14 weeks

Sponsors & Collaborators

  • University of Modena

    collaborator UNKNOWN

  • University of Modena and Reggio Emilia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-06-30
Completion
2009-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00974714 on ClinicalTrials.gov